IVF Total Cost: Compare a $24,000 Cycle With a $35,000 Cycle Before Paying Again

You have a clinic quote, a medication estimate that might change, and a question that feels impossible to answer: “How are we supposed to afford another cycle if this one fails?”

A useful comparison starts with the complete treatment budget and a success measure that covers the same treatment. A retrieval quote leaves out too much. A live birth rate per embryo transfer leaves out patients who never reach transfer.

Below, two illustrative clinic budgets differ by $11,000 for the same listed services. We will calculate what happens across three attempts, then examine insurance and refund terms.

All prices and probabilities in the worked examples are hypothetical assumptions, not current clinic quotes or measured outcomes. The supplied news summaries contain no IVF-specific prices or success rates. Their relevance is to billing, medication access, and financial assistance.

What belongs in your IVF total cost?

Before comparing prices, define the purchase. Does “one cycle” mean starting stimulation, completing an egg retrieval, or completing retrieval plus an embryo transfer?

Those definitions produce different bills.

For this example, both clinics price one retrieval, embryo testing, freezing, and one frozen embryo transfer, assuming an embryo becomes available. A frozen embryo transfer, or FET, places a previously frozen embryo into the uterus.

PGT-A means preimplantation genetic testing for aneuploidy: screening embryos for chromosome-number differences. Its inclusion here is a budgeting assumption, not a recommendation.

Cost component	Example Clinic A	Example Clinic B
Retrieval and embryology package	$13,000	$18,000
Stimulation and transfer medications	$4,000	$6,000
Monitoring appointments and bloodwork	$1,000	$1,500
Anesthesia	$1,000	$1,500
Embryo biopsy and PGT-A laboratory fees	$2,500	$3,500
Freezing and initial storage	$500	$1,000
One FET procedure	$2,000	$3,500
Total modeled cost	$24,000	$35,000

Clinic A’s calculation is:

$13,000 + $4,000 + $1,000 + $1,000 + $2,500 + $500 + $2,000 = $24,000.

The advertised package difference is $5,000. The complete budget difference is $11,000.

These examples exclude travel, lost wages, donor-related expenses, additional transfers, and extended storage. Add those separately when they apply.

Ask each clinic to mark every line as included, separately billed, conditional, or refundable. An itemized quote should also explain what happens financially if treatment stops before retrieval or no embryo reaches transfer.

For more detail, see our guide to IVF quotes, medications, testing, and transfer costs. Use this checklist alongside Feralyx when comparing your own clinic options.

Medication cost is also an access question

A pharmacy estimate needs more than a dollar figure. It needs the prescribed quantity, dispensing pharmacy, coverage decision, and expected delivery date.

The supplied summary of KFF Health News’s “Patient Dies by Suicide After ‘Insurance Issue’ Delayed Medicine for Lung Disease Flare-Ups” describes a devastating case involving delayed medication access. It concerns COPD, not fertility treatment, and does not establish how often IVF prescriptions face delays.

The practical connection is narrower: a prescription and an insurance benefit do not establish that medication is ready to dispense.

Before counting medication coverage in your budget, establish:

• Which fertility drugs require authorization.
• Whether the plan requires a particular specialty pharmacy.
• Whether medication spending reduces a separate fertility benefit.
• What happens if the prescribed quantity changes.
• Whether the cash price and insurance price cover identical quantities.

In the example above, increasing Clinic A’s medication bill from $4,000 to $6,000 raises the episode total to $26,000. Across three identical episodes, that difference becomes $6,000.

Your clinician determines the prescription. Your comparison should capture its financial consequences without assuming that a cheaper medication estimate represents an equivalent protocol.

Match the success rate to what you are buying

Start with the Society for Assisted Reproductive Technology’s SART Patient Predictor and national and clinic reports.

Record the reporting year, age group, egg source, outcome, denominator, and follow-up window beside every number. Published clinic results are historical group outcomes, not personal guarantees.

A clinic’s live birth rate per transfer answers a different question from its live birth rate per intended retrieval. A strong transfer rate does not describe the probability of reaching transfer.

Cancellation rates also need context. A high rate can reflect patient mix or clinical decisions; it does not independently prove poor care or manipulation.

Use FertilityIQ’s clinic reviews and ratings to investigate patient experience, including communication and billing. Record the review count and dates. A patient-experience rating cannot substitute for a live birth rate, and neither establishes what you personally will pay.

Our guide to reading SART clinic data by age explains the denominator problem in more detail.

What do three IVF attempts actually buy?

For a transparent calculation, assume:

• Clinic A costs $24,000 per episode and has a hypothetical 35% live birth probability.
• Clinic B costs $35,000 per episode and has a hypothetical 45% probability.
• Each episode covers one retrieval and, if possible, one transfer.
• Everyone without a live birth continues, up to three episodes.

The model excludes additional transfers from remaining embryos. It therefore must not be described as SART’s cumulative outcome across all associated transfers.

If the conditional chance remains the same each time:

Probability of at least one live birth after n attempts = 1 − (1 − p)ⁿ.

Maximum attempts	Clinic A: 35% per attempt	Clinic B: 45% per attempt	A: full budget	B: full budget
1	35.0%	45.0%	$24,000	$35,000
2	57.8%	69.8%	$48,000	$70,000
3	72.5%	83.4%	$72,000	$105,000

For Clinic A, three-attempt probability is:

1 − 0.65³ = 72.5375%.

Clinic B’s modeled advantage after three attempts is 10.825 percentage points, with a $33,000 larger full budget.

That calculation does not establish that the more expensive clinic is better. The assumed probabilities would need support from comparable patient groups, and previous treatment results can change the estimate.

After a failed attempt, a patient does not acquire the original three-attempt probability for their remaining treatment. Update the forecast using what the clinical team learned.

Age and diagnosis change the inputs, not just the label

For treatment using your own eggs, ages 35, 38, and 41 fall into different SART reporting groups: 35–37, 38–40, and 41–42. Use the relevant group as a starting point, then discuss its applicability with the clinic.

AMH, or anti-Müllerian hormone, and AFC, or antral follicle count, help clinicians assess ovarian reserve and likely response. Neither is a standalone live birth probability.

Diagnosis, prior response, egg source, and treatment history can change both the expected treatment pathway and the budget. OHSS, ovarian hyperstimulation syndrome, is a complication of ovarian stimulation; questions about its risk and management belong with your clinician.

Rather than assign an invented probability to each age, test several possibilities:

Hypothetical probability per attempt	After 2 attempts	After 3 attempts	Full three-attempt budget at $24,000
20%	36.0%	48.8%	$72,000
35%	57.8%	72.5%	$72,000
50%	75.0%	87.5%	$72,000

The same spending supports very different modeled outcomes. These are sensitivity scenarios, not age-specific success rates.

Bring your age group, diagnosis, previous results, and itemized quotes to Feralyx so your comparison starts with the inputs that matter to you.

Expected spending is different from the cash you might need

If patients stop after a live birth, everyone pays for attempt one, but only some pay for attempts two and three.

Under Clinic A’s assumptions:

Expected attempts = 1 + 0.65 + 0.65² = 2.0725.

Expected spending = $24,000 × 2.0725 = $49,740.

Clinic B’s expected spending is:

$35,000 × (1 + 0.55 + 0.55²) = $64,837.50.

These are averages across hypothetical groups. An individual still needs a plan for the actual bills they encounter, potentially $72,000 or $105,000.

This model also charges the full episode price even when treatment ends early. Real cancellation credits and unused-transfer refunds would change it.

Location adds another layer. A hypothetical $2,500 in travel and accommodation per episode raises Clinic A’s three-attempt budget by $7,500. Include missed work and local monitoring separately, using your own estimates.

Insurance and hospital assistance can reverse the comparison

Suppose written benefit estimates show insurance paying $10,000 toward Clinic A’s $24,000 bill and $18,000 toward Clinic B’s $35,000 bill.

Your modeled responsibility becomes:

• Clinic A: $14,000.
• Clinic B: $17,000.

The original $11,000 difference shrinks to $3,000.

This simplified example assumes those payments are confirmed and already account for deductibles and cost-sharing. Real estimates must distinguish billed charges, negotiated amounts, excluded services, and remaining benefit limits.

KFF Health News’s “Hospitals Have a Little-Known Tool To Prevent Medical Debt. Here’s How It Works.” describes presumptive eligibility, through which hospitals identify eligible patients for financial assistance.

That reporting does not establish that IVF qualifies. Ask whether the hospital’s policy covers your specific facility and anesthesia charges, and whether separately billing clinicians participate. A freestanding fertility clinic may have entirely different policies.

KFF’s “Midterms Have Revived Universal Healthcare Debate. These States Are Ahead of Everyone.” describes coverage proposals. A proposal does not fund today’s treatment. Budget against your effective plan documents and written determinations.

Our IVF insurance coverage guide provides additional questions for benefits administrators.

Is a refund program cheaper than paying per cycle?

Consider a hypothetical program charging $48,000 upfront, covering up to three episodes, with a full program-fee refund if no live birth occurs. Medications cost another $4,000 per attempted episode and are never refunded.

Assume equivalent services, a 35% conditional chance per attempt, and full compliance with the refund contract.

Expected net spending is:

$48,000 × 72.5375% + $4,000 × 2.0725 = $43,108.

Compare that with $49,740 expected spending under Clinic A’s pay-per-cycle model.

But early success changes the experience dramatically:

Outcome	Pay per cycle	Refund program, including medications
Live birth after first episode	$24,000	$52,000
Three unsuccessful episodes	$72,000	$12,000 after refund

The program’s modeled expected-cost advantage is $6,632. Its first-attempt cash requirement is much larger.

Check eligibility, withdrawal rules, excluded services, refund timing, and the contractual definition of success. Nobody should assume that stopping treatment voluntarily triggers the same refund as completing the program.

NerdWallet’s “Should U.S. Bank’s New Credit Cards be ‘Essential’ for Your Business?” concerns business cards. Its supplied summary establishes no suitable patient financing offer. Compare an actual financing disclosure’s APR, fees, payment schedule, and total repayment before adding debt to either option.

Compare the next decision with your own numbers

The remaining KFF article, “Journalists Evaluate Rural Voter Sentiment, MAHA Movement, and Gene-Editing Finding,” is a media-appearance roundup. Its supplied summary provides no basis for changing an IVF cost or success estimate.

Your decision needs more specific evidence: two complete quotes, comparable outcome measures, written insurance estimates, and a budget for continuing or stopping.

A spreadsheet cannot decide what another attempt means emotionally. It can make the financial commitment clearer before you make it.

Start your IVF clinic comparison with Feralyx, using your own costs, coverage, and treatment history.

Sources

• Journalists Evaluate Rural Voter Sentiment, MAHA Movement, and Gene-Editing Finding — KFF Reproductive Health
• Should U.S. Bank’s New Credit Cards be ‘Essential’ for Your Business? — NerdWallet Health
• Patient Dies by Suicide After ‘Insurance Issue’ Delayed Medicine for Lung Disease Flare-Ups — KFF Reproductive Health
• Midterms Have Revived Universal Healthcare Debate. These States Are Ahead of Everyone. — KFF Reproductive Health
• Hospitals Have a Little-Known Tool To Prevent Medical Debt. Here’s How It Works. — KFF Reproductive Health